Literature DB >> 4842257

Proceedings: Tumor angiogenesis factor.

J Folkman.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4842257

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  78 in total

Review 1.  Cancer nanomedicines targeting tumor extracellular pH.

Authors:  Li Tian; You Han Bae
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-25       Impact factor: 5.268

2.  A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF.

Authors:  J Wilting; B Christ; M Bokeloh
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 4.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

Review 5.  Cell kinetics and radiation pathology.

Authors:  J Denekamp; A Rojas
Journal:  Experientia       Date:  1989-01-15

6.  VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.

Authors:  Revu Ann Alexander; Gerald W Prager; Judit Mihaly-Bison; Pavel Uhrin; Stefan Sunzenauer; Bernd R Binder; Gerhard J Schütz; Michael Freissmuth; Johannes M Breuss
Journal:  Cardiovasc Res       Date:  2012-01-26       Impact factor: 10.787

Review 7.  Angiogenesis as a target for breast cancer therapy.

Authors:  D Rayson; S A Vantyghem; A F Chambers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-10       Impact factor: 2.673

8.  Utilization of in vivo alkylated metabolites as a possible cause of increased sensitivity to tumor cells to alkylating agents.

Authors:  M I Lerman; O Y Abakumova; N G Kutcenko; I S Sokolova; L B Gorbachieva; A M Serebryannyl
Journal:  Mol Biol Rep       Date:  1975-07       Impact factor: 2.316

9.  The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors.

Authors:  Sophia Ran; Khalid A Mohamedali; Troy A Luster; Philip E Thorpe; Michael G Rosenblum
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

10.  Determination of proliferative compartments in human tumors.

Authors:  H M Rabes; P Carl; U Rattenhuber
Journal:  Experientia       Date:  1978-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.